Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver
The DOI matches its Crossref record.
Abstract
The two major insulin-like growth factor-binding protein (IGFBP) species in the human circulation, IGFBP-1 and IGFBP-3, are synthesized in large amounts by liver. To determine which hepatic cell populations in human liver were responsible for the synthesis and release of these IGFBPs, we 1) performed in situ hybridization with specific complementary RNA (RNA) probes for human IGFBP-1 or-3 or performed immunohistochemical analysis to reveal the sites of messenger RNA (mRNA) presence and peptide translation, respectively, in sections of normal liver derived from organ donors; and 2) examined the release of IGFBP species by Western ligand and immunoblots of medium conditioned by isolated cultures of hepatocytes, lipocytes, and Kupffer cells. In situ hybridization showed that IGFBP-1 mRNA was distributed widely among the parenchymal cell population, which also showed immunohistochemical staining for IGFBP-1 peptide. Conversely, IGFBP-3 mRNA and immunoreactive peptide were mainly localized to Kupffer cells, which were positively identified by immunoreactivity with antiserum against the glycoprotein marker, CD68. Isolated hepatocytes released two species of IGFBP of 28 and 30-32 kilodaltons, which were recognized immunologically as IGFBP-1. Isolated Kupffer cells released only a 43- to 46-kilodalton IGFBP immunologically recognized as IGFBP-3. Lipocyte cultures released no detectable IGFBP species. The results suggest that IGFBP-1 and IGFBP-3 are derived from separate cell populations in human liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
Kelley, K. M., Oh, Y., Gargosky, S. E., Gucev, Z., Matsumoto, T., Hwa, V., Ng, L., Simpson, D. M., & Rosenfeld, R. G. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(96)00005-2 · Cited by 479
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Juul, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00038-8 · Cited by 467
Dehkhoda, F., Lee, C. M. M., Medina, J., & Brooks, A. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00035 · Cited by 304
“It also has a role in the production of IGFBP-3 by Kupffer cells (231, 232).”
BackgroundInsulin-Like Growth Factor Binding Proteins: New Proteins, New Functions
Ferry Jr., R. J., Cerri, R. W., & Cohen, P. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023315 · Cited by 205
Cellular Actions of Insulin-Like Growth Factor Binding Proteins
Ferry, R., Katz, L., Grimberg, A., Cohen, P., & Weinzimer, S. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978719 · Cited by 166
Schmid, C., Zwimpfer, C., Brändle, M., Krayenbühl, P., Zapf, J., & Wiesli, P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02652.x · Cited by 29
IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis
Ronsoni, M. F., Lazzarotto, C., Fayad, L., Silva, M. C., Nogueira, C. L., Bazzo, M. L., Narciso-Schiavon, J. L., Dantas-Corrêa, E. B., & Schiavon, L. D. L. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31009-9 · Cited by 20
Metadata
- Authors
- Arany, E.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-12-01
- Volume
- 79
- Issue
- 6
- Pages
- 1871-1876
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1998109631
- Cited by
- 100
- References
- 0
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.